83 FR 15175 - Importer of Controlled Substances Application: United States
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 68 (April 9, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 68 (April 9, 2018)
| Page Range | 15175-15176 | |
| FR Document | 2018-07167 |
[Federal Register Volume 83, Number 68 (Monday, April 9, 2018)] [Notices] [Pages 15175-15176] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-07167] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: United States ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 9, 2018. Such persons may also file a written request for a hearing on the application on or before May 9, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on March 1, 2018, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, MD, 20852 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Cathinone................................ 1235 I Methaqualone............................. 2565 I Lysergic acid diethylamide............... 7315 I 4-Methyl-2,5-dimethoxyamphetamine........ 7395 I 4-Methoxyamphetamine..................... 7411 I Codeine-N-oxide.......................... 9053 I Difenoxin................................ 9168 I Heroin................................... 9200 I Morphine-N-oxide......................... 9307 I Norlevorphanol........................... 9634 I Methamphetamine.......................... 1105 II Phenmetrazine............................ 1631 II Methylphenidate.......................... 1724 II Amobarbital.............................. 2125 II Pentobarbital............................ 2270 II Secobarbital............................. 2315 II Glutethimide............................. 2550 II Phencyclidine............................ 7471 II Phenylacetone............................ 8501 II Alphaprodine............................. 9010 II Anileridine.............................. 9020 II Cocaine.................................. 9041 II [[Page 15176]] Dihydrocodeine........................... 9120 II Diphenoxylate............................ 9170 II Levomethorphan........................... 9210 II Levorphanol.............................. 9220 II Meperidine............................... 9230 II Dextropropoxyphene, bulk (non-dosage 9273 II forms). Thebaine................................. 9333 II Noroxymorphone........................... 9668 II Alfentanil............................... 9737 II Sufentanil............................... 9740 II ------------------------------------------------------------------------ The company plans to import the bulk controlled substances for distribution of analytical reference standards to its customers for research and analytical purposes. Dated: April 2, 2018. Susan A. Gibson, Deputy Assistant Administrator. [FR Doc. 2018-07167 Filed 4-6-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices 15175
Dated: April 3, 2018. activity of the group research project. Administration, Attention: DEA Federal
Elizabeth K. Appel, Membership in this group research Register Representative/DRW, 8701
Director, Office of Regulatory Affairs and project remains open, and UHD Alliance Morrissette Drive, Springfield, Virginia
Collaborative Action—Indian Affairs. intends to file additional written 22152. All requests for hearing must be
[FR Doc. 2018–07122 Filed 4–6–18; 8:45 am] notifications disclosing all changes in sent to: Drug Enforcement
BILLING CODE 4337–15–P membership. Administration, Attn: Administrator,
On June 17, 2015, UHD Alliance filed 8701 Morrissette Drive, Springfield,
its original notification pursuant to Virginia 22152. All request for hearing
DEPARTMENT OF JUSTICE Section 6(a) of the Act. The Department should also be sent to: (1) Drug
of Justice published a notice in the Enforcement Administration, Attn:
Antitrust Division Federal Register pursuant to Section
Hearing Clerk/LJ, 8701 Morrissette
6(b) of the Act on July 17, 2015 (80 FR
Notice Pursuant to the National Drive, Springfield, Virginia 22152; and
42537).
Cooperative Research and Production The last notification was filed with (2) Drug Enforcement Administration,
Act of 1993—UHD Alliance, Inc. the Department on December 15, 2017. Attn: DEA Federal Register
A notice was published in the Federal Representative/DRW, 8701 Morrissette
Notice is hereby given that, on March Register pursuant to Section 6(b) of the Drive, Springfield, Virginia 22152.
8, 2018, pursuant to Section 6(a) of the
Act on February 12, 2018 (83 FR 6051). SUPPLEMENTARY INFORMATION: The
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301 Patricia A. Brink, Attorney General has delegated his
et seq. (‘‘the Act’’), UHD Alliance, Inc. Director of Civil Enforcement, Antitrust authority under the Controlled
(‘‘UHD Alliance’’) filed written Division. Substances Act to the Administrator of
notifications simultaneously with the [FR Doc. 2018–07129 Filed 4–6–18; 8:45 am] the Drug Enforcement Administration
Attorney General and the Federal Trade BILLING CODE 4410–11–P (DEA), 28 CFR 0.100(b). Authority to
Commission disclosing changes in its exercise all necessary functions with
membership. The notifications were respect to the promulgation and
filed for the purpose of extending the DEPARTMENT OF JUSTICE implementation of 21 CFR part 1301,
Act’s provisions limiting the recovery of incident to the registration of
antitrust plaintiffs to actual damages Drug Enforcement Administration manufacturers, distributors, dispensers,
under specified circumstances. [Docket No. DEA–392] importers, and exporters of controlled
Specifically, Google, Inc., Mountain substances (other than final orders in
View, CA; Teledyne LeCroy, Elgin, IL; Importer of Controlled Substances connection with suspension, denial, or
and Synaptics, San Jose, CA, have been Application: United States revocation of registration) has been
added as parties to this venture. delegated to the Assistant Administrator
Also, HDAnywhere Ltd., Malvern, ACTION: Notice of application. of the DEA Diversion Control Division
UNITED KINGDOM; Quantum Data, (‘‘Assistant Administrator’’) pursuant to
Inc., Elgin, IL; and Sky UK Ltd., DATES: Registered bulk manufacturers of
the affected basic classes, and section 7 of 28 CFR part 0, appendix to
Isleworth, UNITED KINGDOM, have subpart R.
withdrawn as parties to this venture. applicants therefore, may file written
In addition, the following members comments on or objections to the In accordance with 21 CFR
have changed their names: Koninklijke issuance of the proposed registration on 1301.34(a), this is notice that on March
Philips N.V. to Philips International or before May 9, 2018. Such persons 1, 2018, United States Pharmacopeial
B.V.–IP&S, Eindhoven, may also file a written request for a Convention, 12601 Twinbrook Parkway,
NETHERLANDS; and DTS, Inc., to hearing on the application on or before Rockville, MD, 20852 applied to be
Xperi Corporation, Calabasas, CA. May 9, 2018. registered as an importer of the
No other changes have been made in ADDRESSES: Written comments should following basic classes of controlled
either the membership or planned be sent to: Drug Enforcement substances:
Controlled substance Drug code Schedule
Cathinone ........................................................................................................................................................................ 1235 I
Methaqualone .................................................................................................................................................................. 2565 I
Lysergic acid diethylamide .............................................................................................................................................. 7315 I
4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I
4-Methoxyamphetamine .................................................................................................................................................. 7411 I
Codeine-N-oxide .............................................................................................................................................................. 9053 I
Difenoxin .......................................................................................................................................................................... 9168 I
Heroin .............................................................................................................................................................................. 9200 I
Morphine-N-oxide ............................................................................................................................................................ 9307 I
Norlevorphanol ................................................................................................................................................................ 9634 I
Methamphetamine ........................................................................................................................................................... 1105 II
Phenmetrazine ................................................................................................................................................................. 1631 II
Methylphenidate .............................................................................................................................................................. 1724 II
Amobarbital ...................................................................................................................................................................... 2125 II
sradovich on DSK3GMQ082PROD with NOTICES
Pentobarbital .................................................................................................................................................................... 2270 II
Secobarbital ..................................................................................................................................................................... 2315 II
Glutethimide ..................................................................................................................................................................... 2550 II
Phencyclidine ................................................................................................................................................................... 7471 II
Phenylacetone ................................................................................................................................................................. 8501 II
Alphaprodine .................................................................................................................................................................... 9010 II
Anileridine ........................................................................................................................................................................ 9020 II
Cocaine ............................................................................................................................................................................ 9041 II
VerDate Sep<11>2014 18:06 Apr 06, 2018 Jkt 244001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\09APN1.SGM 09APN1](https://thefederalregister.org/doc/83_FR_15243/page/1.svg)
![15176 Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices
Controlled substance Drug code Schedule
Dihydrocodeine ................................................................................................................................................................ 9120 II
Diphenoxylate .................................................................................................................................................................. 9170 II
Levomethorphan .............................................................................................................................................................. 9210 II
Levorphanol ..................................................................................................................................................................... 9220 II
Meperidine ....................................................................................................................................................................... 9230 II
Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II
Thebaine .......................................................................................................................................................................... 9333 II
Noroxymorphone ............................................................................................................................................................. 9668 II
Alfentanil .......................................................................................................................................................................... 9737 II
Sufentanil ......................................................................................................................................................................... 9740 II
The company plans to import the bulk or before May 9, 2018. Such persons SUPPLEMENTARY INFORMATION: The
controlled substances for distribution of may also file a written request for a Attorney General has delegated his
analytical reference standards to its hearing on the application on or before authority under the Controlled
customers for research and analytical May 9, 2018. Substances Act to the Administrator of
purposes. the Drug Enforcement Administration
ADDRESSES: Written comments should (DEA), 28 CFR 0.100(b). Authority to
Dated: April 2, 2018. be sent to: Drug Enforcement
Susan A. Gibson, exercise all necessary functions with
Administration, Attention: DEA Federal respect to the promulgation and
Deputy Assistant Administrator. Register Representative/DRW, 8701 implementation of 21 CFR part 1301,
[FR Doc. 2018–07167 Filed 4–6–18; 8:45 am] Morrissette Drive, Springfield, Virginia incident to the registration of
BILLING CODE 4410–09–P 22152. All requests for hearing must be manufacturers, distributors, dispensers,
sent to: Drug Enforcement importers, and exporters of controlled
Administration, Attn: Administrator, substances (other than final orders in
DEPARTMENT OF JUSTICE 8701 Morrissette Drive, Springfield, connection with suspension, denial, or
Drug Enforcement Administration Virginia 22152. All request for hearing revocation of registration) has been
should also be sent to: (1) Drug delegated to the Assistant Administrator
[Docket No. DEA–392] Enforcement Administration, Attn: of the DEA Diversion Control Division
Hearing Clerk/LJ, 8701 Morrissette (‘‘Assistant Administrator’’) pursuant to
Importer of Controlled Substances Drive, Springfield, Virginia 22152; and section 7 of 28 CFR part 0, appendix to
Application: AMRI Rensselaer, Inc. (2) Drug Enforcement Administration, subpart R.
ACTION: Notice of application. Attn: DEA Federal Register In accordance with 21 CFR
Representative/DRW, 8701 Morrissette 1301.34(a), this is notice that on March
DATES: Registered bulk manufacturers of Drive, Springfield, Virginia 22152. 21, 2018, AMRI Rensselaer, 33 Riverside
the affected basic classes, and Comments and requests for hearings on Ave., Rensselaer, NY 12144, applied to
applicants therefore, may file written applications to import narcotic raw be registered as an importer of the
comments on or objections to the material are not appropriate. 72 FR 3417 following basic class of controlled
issuance of the proposed registration on (January 25, 2007). substance:
Controlled substance Drug code Schedule
Poppy Straw Concentrate ............................................................................................................................................... 9670 II
The company plans to import the ACTION: Notice of meetings. for the Arts, Washington, DC 20506;
listed controlled substance to hales@arts.gov, or call 202/682–5696.
manufacture bulk controlled substance SUMMARY: Pursuant to the Federal
Advisory Committee Act, as amended, SUPPLEMENTARY INFORMATION: The
for distribution to its customers. closed portions of meetings are for the
notice is hereby given that 2 meetings of
Dated: April 2, 2018. purpose of Panel review, discussion,
the Arts Advisory Panel to the National
Susan A. Gibson,
Council on the Arts will be held by evaluation, and recommendations on
Deputy Assistant Administrator. teleconference unless otherwise noted. financial assistance under the National
[FR Doc. 2018–07165 Filed 4–6–18; 8:45 am] Foundation on the Arts and the
DATES: See the SUPPLEMENTARY Humanities Act of 1965, as amended,
BILLING CODE 4410–09–P
INFORMATION section for individual including information given in
meeting times and dates. All meetings confidence to the agency. In accordance
are Eastern time and ending times are with the determination of the Chairman
approximate: of July 5, 2016, these sessions will be
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES ADDRESSES: National Endowment for the closed to the public pursuant to
sradovich on DSK3GMQ082PROD with NOTICES
Arts, Constitution Center, 400 7th St. subsection (c)(6) of section 552b of title
National Endowment for the Arts SW, Washington, DC 20506. 5, United States Code.
FOR FURTHER INFORMATION CONTACT: The upcoming meetings are:
Arts Advisory Panel Meetings
Further information with reference to Literature Fellowships: Translation
AGENCY: National Endowment for the these meetings can be obtained from Ms. Projects (review of applications): This
Arts, National Foundation on the Arts Sherry P. Hale, Office of Guidelines & meeting will be closed. Date and time:
and Humanities. Panel Operations, National Endowment May 16, 2018; 3:00 p.m. to 5:00 p.m.
VerDate Sep<11>2014 18:06 Apr 06, 2018 Jkt 244001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\09APN1.SGM 09APN1](https://thefederalregister.org/doc/83_FR_15243/page/2.svg)
Document Created: 2018-04-07 02:39:21
Document Modified: 2018-04-07 02:39:21
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 9, 2018. Such persons may also file a written request for a hearing on the application on or before May 9, 2018. | |
| FR Citation | 83 FR 15175 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR